As discussed before, in the previous part of this article, we shared about the problems raised by genome-testing-based service, they’re still currently under development and heavy research, also this service raises many privacy concerns. To solve problems raised by the development and implementation of this technology we need to create 2 new basic infrastructures and gradually update the old system.
Genome Database Platform That Cares about Privacy
Simply, in solving the scarcity problem of genome data needed for research and development of the genome-based technology there’s a need of a genome database platform which simply stores a lot of genome data of users that agree their data is being used, which can be accessed easily by anyone, but without incercinating the privacy of their users. This can create a direct-to-consumer genomics business more open, fair, and beneficial for both sides, the genome owner and the researcher or other general user (ex. Medical company, etc)
Shivom is one of the first company trying to solve this problems. Project Shivom is powering the next era of genomics through the blockchain technology - protecting identity, personalizing healthcare and transforming lives. A precision medicine ecosystem will offer an open web-marketplace for other providers to add not only genomics information, but also analytics, and associated apps and services to drive personalized medicine.
Shivom, the blockchain-powered global 'Unique ID' genomic database platform, has announced a major partnership with leading molecular diagnostics company Genetic Technologies. Advancing what is, potentially, a life-saving application of the blockchain, this partnership is born with attempt to accelerate the cancer prediction rate for millions worldwide.
Shivom would be operating in a vital industry. We live in an era where genomic medicine has the potential to increase the understanding of, and provide treatment for as many as 7000 rare diseases, as well as address major global killers such as cancer, heart disease and diabetes. The project will use blockchain technology to change the way modern medicine works. The blockchain implementation would allow Shivom to address important issues relating to consent, data ownership, data integrity and authentication. The ability to use smart contract technology would be an additional benefit as it can allow for management of complex data rights as well as fine grained access. The process of sequencing is painless for donors as all that is required is a saliva sample. In return donors would benefit from getting information about their health and ancestry, and can decide if they want to donate their genome for free or profit.
Shivom is currently holding an ICO to accelerate their core company development. For more information please visit https://shivom.io/
Special Thanks to Project Shivom for making this article possible! Check out their Twitter or Facebook Page to ask more about their project!